Moreover, research has focused on the impact of aggregated alpha-synuclein on mitochondrial dysfunction, mitochondrial biogenesis changes, and lysosomal disease-mediated neurodegeneration in PD, as illustrated in Fig. 2. This evidence concerns the gene SNCA and Parkinson disease.